TransCode Therapeutics (RNAZ) Q4 2025 Earnings

14NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-56
-39.09
-22.19
-5.28

Details

Expected EPS
-9.24
Actual EPS
N/A
Surprise EPS
9.24
Surprise Percent
+100%

Description

TransCode Therapeutics (RNAZ) will report earnings of for Q4 2025 on November 14, 2025.

0 Comments

Share your thoughts